Top Markets
Coin of the day
Senores Pharmaceuticals Ltd. Senores Pharmaceuticals Ltd.

Senores Pharmaceuticals Ltd.

SENORES
Rank in Stocks #11030
Established in 2017 and headquartered in Ahmedabad, India, Senores... Established in 2017 and headquartered in Ahmedabad, India, Senores Pharmaceuticals Ltd. is actively involved in the development, manufacturing, and global commercialization of pharmaceutical and related products. Its extensive portfolio reaches markets across India, the United States, the United Kingdom, Canada, and other international territories. The company specializes in a diverse array of therapeutic solutions, encompassing analgesics/antipyretics, anesthetics, antibacterials, antivirals, antifungals, antioxidants, antineoplastics, blood-related therapies, cardiovascular and neurological medications, antacids, and vitamin and mineral supplements. Additionally, Senores offers a selection of generic drugs targeting pain, inflammation, fever, diabetes, malaria, and urinary tract conditions, as well as neutral supplements. Complementing its product offerings, the firm also provides management and consultancy services.
Share Price
$16.36
Last synced: 2026-08-28
Market Cap
$753.27M
Change (1 day)
0.51%
Change (1 year)
108.95%
Country
IN
Trade Senores Pharmaceuticals Ltd. (SENORES)

Category

Earnings for Senores Pharmaceuticals Ltd. (SENORES)
Earnings in 2026 TTM: 0
According to Senores Pharmaceuticals Ltd. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Senores Pharmaceuticals Ltd. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$33.59B -
US
$25.20B -
US
$8.70B -
US
$21.39B -
CH
$5.95B -
US